Vinayak Remedies Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 10-12-2024
- Paid Up Capital ₹ 1.40 M
as on 10-12-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.70 Cr
as on 10-12-2024
- Revenue 30.60%
(FY 2022)
- Profit 15.37%
(FY 2022)
- Ebitda 24.96%
(FY 2022)
- Net Worth 25.47%
(FY 2022)
- Total Assets 16.51%
(FY 2022)
About Vinayak Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 1.40 M.
The company currently has active open charges totaling ₹1.70 Cr.
Kusum Mittal, Jyoti Goel, Suman Goyal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231DL2006PLC146801
- Company No.
146801
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vinayak Remedies?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kusum Mittal | Director | 23-Jun-2023 | Current |
Jyoti Goel | Director | 24-Feb-2006 | Current |
Suman Goyal | Director | 23-Jun-2023 | Current |
Chirag Mittal | Director | 23-Jun-2023 | Current |
Financial Performance of Vinayak Remedies.
Vinayak Remedies Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.6% increase. The company also saw a substantial improvement in profitability, with a 15.37% increase in profit. The company's net worth Soared by an impressive increase of 25.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Vinayak Remedies?
In 2022, Vinayak Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shree Mahalakshmi Strips LtdActive 28 years 5 months
Kusum Mittal and Chirag Mittal are mutual person
- Glovion Concepts Private LimitedActive 5 months 21 days
Kusum Mittal and Chirag Mittal are mutual person
- Shree Ambika Impex LimitedActive 28 years 10 months
Kusum Mittal and Chirag Mittal are mutual person
- Chintpurni Securities LimitedActive 29 years 6 months
Kusum Mittal and Chirag Mittal are mutual person
- Shefali Securities Private LimitedActive 29 years 6 months
Kusum Mittal and Chirag Mittal are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 29 Sep 2023 | ₹1.70 Cr | Open |
How Many Employees Work at Vinayak Remedies?
Unlock and access historical data on people associated with Vinayak Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vinayak Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vinayak Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.